Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06743906

Role of OCT & OCT Angiography in Patients With Posterior at the Uveitis Clinic of Assiut University Hospital.

OCT angiography is a recent evaluation of OCT technology which combines the structural assessment of ocular tissues obtained by OCT image with visualization of blood flow within the vessels in imaged area. So combined structural and function image can be obtained by OCT angiography.

Defferent type of uveitis often have specific OCT & OCT angiography findingwhich deffer according to the involved ocular tissue and according to the type of inflammatory / infectious process that characterize them.

The aim of study is to determine the role of OCT & OCT angiography in assessment of retinal and choroidal architectural and vascular changes in patients with posterior uveitis.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Uveitis is a challenging disease. It represents a major cause of ocular morbidity worldwide. More than half of all patients with uveitis develop sight threatening complications related to their disease, and up to 35% of patients suffer severe visual impairment.

Uveitis and its complications are responsible for 5% to 10% of all causes of legal blindness in developed countries .

The causes of uveitis are numerous, and include infectious conditions, autoimmune diseases, trauma and tumors (masquerade syndrome). To develop an accurate differential diagnosis, clinicians must consider all available information, including the patient history, anatomic location of the inflammation (anterior or posterior), character (granulomatous vs. non granulomatous), laterality, and chronicity of inflammation. Moreover, diagnostic tools, such as fluorescein angiography (FA), indocyanine green angiography (ICG), optical coherence tomography (OCT) and ultrasound, play an important role in the diagnosis and in the management of the uveitis.

OCT & OCT angiography are now proven to be an effective noninvasive method in detecting pathologic features in uveitis and are rapidly gaining popularity as an ancillary exam. It may be used to assist in the diagnosis of uveitis and may be repeated safely during follow-up to monitor response to any intervention.

OCT angiography is a recent evaluation of OCT technology which combines the structural assessment of ocular tissues obtained by OCT image with visualization of blood flow within the vessels in imaged area. So combined structural and function image can be obtained by OCT angiography.

Defferent type of uveitis often have specific OCT & OCT angiography findingwhich deffer according to the involved ocular tissue and according to the type of inflammatory / infectious process that characterize them.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Patient age of greater than 18 years old.
  • Patient can offer viable consent.
  • Patient with posterior uveitis (infectious or non-infectious posterior uveitis).

Exclusion criteria

  • - Patient unable to offer viable consent.
  • Patient unwilling to participate.
  • Any coexistence retinal pathology: diabetic retinopathy, other causes of retinal vascular occlusion, traumatic retinopathy, traumatic maculopathy, other peripheral ischemic retinopathy e.g. sickles cell retinopathy.
  • Presence of media opacity hindering appropriate scan.

Treatment and study plan

Primary outcomes

  1. the choroidal thickness (CT) measurements

    Time frame: baseline

    The choroidal thickness (CT) measurements will be obtained from manual segmentation of OCT B-scans at the fovea for case numbers 1, 2, 4 and 5 and at the location of the choroiditis lesion

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed Lotfy Mahmoud, resident doctor

CONTACT

[email protected]

+20 11 00571623

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 20, 2024
Registry last updated
Apr 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.